Relay Therapeutics CFO Thomas Catinazzo disposes of 17,717 common shares worth $349,703.58
RLAY•CFO share sale disclosed in SEC filing
- Relay Therapeutics CFO Thomas Catinazzo sold 17,717 common shares on Aug. 14, 2026 at $19.74 per share.
- Holdings fell to 140,568 shares following the sale.
